tradingkey.logo

Claritev Corp

CTEV
查看详细走势图
42.670USD
+0.890+2.13%
收盘 12/24, 13:00美东报价延迟15分钟
704.46M总市值
亏损市盈率 TTM

Claritev Corp

42.670
+0.890+2.13%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.13%

5天

+11.26%

1月

-9.44%

6月

+2.84%

今年开始到现在

+188.70%

1年

+579.46%

查看详细走势图

TradingKey Claritev Corp股票评分

单位: USD 更新时间: 2025-12-23

操作建议

Claritev Corp当前公司基本面数据相对谨慎,增长潜力很大。当前估值合理,在专业与商业服务行业排名68/156位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价88.33。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Claritev Corp评分

相关信息

行业排名
68 / 156
全市场排名
163 / 4568
所属行业
专业与商业服务

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 3 位分析师
买入
评级
88.333
目标均价
+167.84%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Claritev Corp亮点

亮点风险
Claritev Corp, formerly MultiPlan Corporation, is a healthcare technology, data and insights company. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The Company uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. It uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. It provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
利润高增长
公司净利润处于行业前列,最新年度总收入930.62M美元
估值低估
公司最新PE估值-2.00,处于3年历史低位
机构减仓
最新机构持股17.38M股,环比减少1.37%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值517.77K

Claritev Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Claritev Corp简介

Claritev Corp, formerly MultiPlan Corporation, is a healthcare technology, data and insights company. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The Company uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. It uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. It provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
公司代码CTEV
公司Claritev Corp
CEODalton (Travis S)
网址https://www.claritev.com/

常见问题

Claritev Corp(CTEV)的当前股价是多少?

Claritev Corp(CTEV)的当前股价是 42.670。

Claritev Corp的股票代码是什么?

Claritev Corp的股票代码是CTEV。

Claritev Corp股票的52周最高点是多少?

Claritev Corp股票的52周最高点是74.070。

Claritev Corp股票的52周最低点是多少?

Claritev Corp股票的52周最低点是5.610。

Claritev Corp的市值是多少?

Claritev Corp的市值是704.46M。

Claritev Corp的净利润是多少?

Claritev Corp的净利润为-1.65B。

现在Claritev Corp(CTEV)的股票是买入、持有还是卖出?

根据分析师评级,Claritev Corp(CTEV)的总体评级为买入,目标价格为88.333。

Claritev Corp(CTEV)股票的每股收益(EPS TTM)是多少

Claritev Corp(CTEV)股票的每股收益(EPS TTM)是-20.916。
KeyAI